As stated in Methods, we have used polyclonal antibody for PD-L1, as a previous study in colorectal carcinomas have shown that either monoclonal or polyclonal antibodies were able to predict colorectal cancer patients overall survival in the same manner [22]. The gene discussed is CD274; the disease is colorectal carcinoma.